Invention Grant
US08524902B2 [1,2,4]triazolo[4,3-f]pteridines useful as inhibitors of protein kinases
有权
[1,2,4]三唑并[4,3-f]蝶啶可用作蛋白激酶的抑制剂
![[1,2,4]triazolo[4,3-f]pteridines useful as inhibitors of protein kinases](/docs/US/2013-09-03/US08524902B2/abs.jpg.600x600.jpg)
- Patent Title: [1,2,4]triazolo[4,3-f]pteridines useful as inhibitors of protein kinases
- Patent Title (中): [1,2,4]三唑并[4,3-f]蝶啶可用作蛋白激酶的抑制剂
-
Application No.: US13253196Application Date: 2011-10-05
-
Publication No.: US08524902B2Publication Date: 2013-09-03
- Inventor: Jean-Damien Charrier , David Kay , Ronald Knegtel
- Applicant: Jean-Damien Charrier , David Kay , Ronald Knegtel
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Agent Rory C. Stewart
- Main IPC: C07D213/26
- IPC: C07D213/26
![[1,2,4]triazolo[4,3-f]pteridines useful as inhibitors of protein kinases](/abs-image/US/2013/09/03/US08524902B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to compounds useful as inhibitors of protein kinase, represented by Structural Formula (I): wherein the variables in Structural Formula (I) are as described herein. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
Public/Granted literature
- US20120277425A1 TETRAHYDROPTERIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES Public/Granted day:2012-11-01
Information query
